Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab

Saved in:
Bibliographic Details
Main Authors: Liana Victory, MB, BCh, BAO, MRCPI, Gregg Murray, MB, BCh, BAO, MRCPI, Claire Quigley, MB, BCh, BAO, MRCPI, Stephanie Bowe, MD, MRCPI, Cliona Feighery, MB, BCh, BAO, Ann Fortune, MB, BCh, BAO, MRCPI, FRCPath, Ian McDonald, MD, MRCPI
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512624005058
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850179793628168192
author Liana Victory, MB, BCh, BAO, MRCPI
Gregg Murray, MB, BCh, BAO, MRCPI
Claire Quigley, MB, BCh, BAO, MRCPI
Stephanie Bowe, MD, MRCPI
Cliona Feighery, MB, BCh, BAO
Ann Fortune, MB, BCh, BAO, MRCPI, FRCPath
Ian McDonald, MD, MRCPI
author_facet Liana Victory, MB, BCh, BAO, MRCPI
Gregg Murray, MB, BCh, BAO, MRCPI
Claire Quigley, MB, BCh, BAO, MRCPI
Stephanie Bowe, MD, MRCPI
Cliona Feighery, MB, BCh, BAO
Ann Fortune, MB, BCh, BAO, MRCPI, FRCPath
Ian McDonald, MD, MRCPI
author_sort Liana Victory, MB, BCh, BAO, MRCPI
collection DOAJ
format Article
id doaj-art-c5e5d4ecb0d346a8b00bd99ac9e93367
institution OA Journals
issn 2352-5126
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj-art-c5e5d4ecb0d346a8b00bd99ac9e933672025-08-20T02:18:24ZengElsevierJAAD Case Reports2352-51262025-03-01579810110.1016/j.jdcr.2024.12.014Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumabLiana Victory, MB, BCh, BAO, MRCPI0Gregg Murray, MB, BCh, BAO, MRCPI1Claire Quigley, MB, BCh, BAO, MRCPI2Stephanie Bowe, MD, MRCPI3Cliona Feighery, MB, BCh, BAO4Ann Fortune, MB, BCh, BAO, MRCPI, FRCPath5Ian McDonald, MD, MRCPI6Department of Dermatology, St George Hospital, Sydney, Australia; Department of Dermatology, Mater Matericordiae University Hospital, Dublin, Ireland; Correspondence to: Liana Victory, MB, BAO, BCh, MRCPI, Department of Dermatology, St George Hospital, Clinical School, UNSW, Kogarah, Sydney, NSW 2217, Australia.Department of Dermatology, Our Lady of Lourdes Hospital, Drogheda, IrelandDepartment of Dermatology, Mater Matericordiae University Hospital, Dublin, IrelandDepartment of Dermatology, Mater Matericordiae University Hospital, Dublin, Ireland; Department of Dermatology, Our Lady of Lourdes Hospital, Drogheda, IrelandDepartment of Dermatology, Our Lady of Lourdes Hospital, Drogheda, IrelandDepartment of Haematology, Mater Misericordiae University Hospital, Dublin, IrelandDepartment of Dermatology, Mater Matericordiae University Hospital, Dublin, Irelandhttp://www.sciencedirect.com/science/article/pii/S2352512624005058biologicsbullous pemphigoiddupilumabimmunobullousomalizumab
spellingShingle Liana Victory, MB, BCh, BAO, MRCPI
Gregg Murray, MB, BCh, BAO, MRCPI
Claire Quigley, MB, BCh, BAO, MRCPI
Stephanie Bowe, MD, MRCPI
Cliona Feighery, MB, BCh, BAO
Ann Fortune, MB, BCh, BAO, MRCPI, FRCPath
Ian McDonald, MD, MRCPI
Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
JAAD Case Reports
biologics
bullous pemphigoid
dupilumab
immunobullous
omalizumab
title Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
title_full Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
title_fullStr Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
title_full_unstemmed Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
title_short Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
title_sort severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
topic biologics
bullous pemphigoid
dupilumab
immunobullous
omalizumab
url http://www.sciencedirect.com/science/article/pii/S2352512624005058
work_keys_str_mv AT lianavictorymbbchbaomrcpi severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab
AT greggmurraymbbchbaomrcpi severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab
AT clairequigleymbbchbaomrcpi severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab
AT stephaniebowemdmrcpi severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab
AT clionafeigherymbbchbao severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab
AT annfortunembbchbaomrcpifrcpath severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab
AT ianmcdonaldmdmrcpi severecaseofbullouspemphigoidassociatedwithnivolumabresponsivetocombinationtherapywithdupilumabandomalizumab